• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Moss Gregory S.

    6/10/25 6:01:58 AM ET
    $AVR
    Industrial Specialties
    Health Care
    Get the next $AVR alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Moss Gregory S.

    (Last) (First) (Middle)
    TOOWONG TOWER, LEVEL 3, SUITE 302
    9 SHERWOOD ROAD

    (Street)
    TOOWONG C3 QLD 4066

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    06/07/2025
    3. Issuer Name and Ticker or Trading Symbol
    Anteris Technologies Global Corp. [ AVR ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    No securities are beneficially owned.
    /s/ Gregory Moss 06/09/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $AVR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AVR

    DatePrice TargetRatingAnalyst
    1/8/2025$20.00Buy
    Lake Street
    1/7/2025$15.00Buy
    TD Cowen
    1/7/2025$9.00Overweight
    Cantor Fitzgerald
    1/7/2025$22.00Overweight
    Barclays
    More analyst ratings

    $AVR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Anteris Appoints David Roberts and Gregory Moss to its Board of Directors

      MINNEAPOLIS and BRISBANE, Australia, June 09, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced the appointments of Mr. David Roberts and Mr. Gregory Moss to its Board of Directors. The Company also announced the resignation of Dr. Wenyi Gu from the Board upon completion of his term as an Australia-based non-executive director. "On behalf of the management team and Board, I am delighted to welcome David and Gregory to the Company" commented John Seaberg, Chairman o

      6/9/25 10:52:06 PM ET
      $AVR
      $LMAT
      Industrial Specialties
      Health Care
      Medical/Dental Instruments
    • Anteris Announces Results for the First Quarter of 2025

      MINNEAPOLIS and BRISBANE, Australia, May 13, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today reported financial results for the quarter ended March 31, 2025, and provided a corporate update. First Quarter 2025 Highlights Investigational Device Exemption ("IDE") for the DurAVR® THV's global, pivotal clinical trial (the "PARADIGM Trial"), submitted to the FDA during the First QuarterScale up for commencement of the PARADIGM Trial ongoing – including expanding the Clinical S

      5/13/25 5:45:28 PM ET
      $AVR
      Industrial Specialties
      Health Care
    • Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV

      MINNEAPOLIS and BRISBANE, Australia, March 31, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris® or the Company) (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices, announces a significant milestone in our mission to restore heart valve patients to healthy function. Our first in class, biomimetic DurAVR® Transcatheter Heart Valve (THV) has now been used to treat over 100 patients worldwide, marking a major achievement in our goal to revolutionize cardiac care in patients affected by severe aortic stenosis. Highlights: Over 100 patients successfully treated with the DurAVR® THV,

      3/31/25 7:15:40 AM ET
      $AVR
      Industrial Specialties
      Health Care

    $AVR
    Leadership Updates

    Live Leadership Updates

    See more
    • Anteris Appoints David Roberts and Gregory Moss to its Board of Directors

      MINNEAPOLIS and BRISBANE, Australia, June 09, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced the appointments of Mr. David Roberts and Mr. Gregory Moss to its Board of Directors. The Company also announced the resignation of Dr. Wenyi Gu from the Board upon completion of his term as an Australia-based non-executive director. "On behalf of the management team and Board, I am delighted to welcome David and Gregory to the Company" commented John Seaberg, Chairman o

      6/9/25 10:52:06 PM ET
      $AVR
      $LMAT
      Industrial Specialties
      Health Care
      Medical/Dental Instruments

    $AVR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street initiated coverage on Anteris Technologies Global Corp. with a new price target

      Lake Street initiated coverage of Anteris Technologies Global Corp. with a rating of Buy and set a new price target of $20.00

      1/8/25 8:52:46 AM ET
      $AVR
      Industrial Specialties
      Health Care
    • TD Cowen initiated coverage on Anteris Technologies Global Corp. with a new price target

      TD Cowen initiated coverage of Anteris Technologies Global Corp. with a rating of Buy and set a new price target of $15.00

      1/7/25 9:02:46 AM ET
      $AVR
      Industrial Specialties
      Health Care
    • Cantor Fitzgerald initiated coverage on Anteris Technologies Global Corp. with a new price target

      Cantor Fitzgerald initiated coverage of Anteris Technologies Global Corp. with a rating of Overweight and set a new price target of $9.00

      1/7/25 9:00:55 AM ET
      $AVR
      Industrial Specialties
      Health Care

    $AVR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Moss Gregory S.

      3 - Anteris Technologies Global Corp. (0002011514) (Issuer)

      6/10/25 6:01:58 AM ET
      $AVR
      Industrial Specialties
      Health Care
    • SEC Form 3 filed by new insider Roberts David B

      3 - Anteris Technologies Global Corp. (0002011514) (Issuer)

      6/10/25 6:01:52 AM ET
      $AVR
      Industrial Specialties
      Health Care
    • Amendment: Director Seaberg John D exercised 40,000 shares at a strike of $7.13 and covered exercise/tax liability with 36,148 shares (SEC Form 4)

      4/A - Anteris Technologies Global Corp. (0002011514) (Issuer)

      3/21/25 9:30:47 AM ET
      $AVR
      Industrial Specialties
      Health Care

    $AVR
    SEC Filings

    See more
    • Anteris Technologies Global Corp. filed SEC Form 8-K: Leadership Update

      8-K - Anteris Technologies Global Corp. (0002011514) (Filer)

      6/9/25 7:00:37 AM ET
      $AVR
      Industrial Specialties
      Health Care
    • SEC Form 10-Q filed by Anteris Technologies Global Corp.

      10-Q - Anteris Technologies Global Corp. (0002011514) (Filer)

      5/13/25 5:22:58 PM ET
      $AVR
      Industrial Specialties
      Health Care
    • Amendment: SEC Form 10-K/A filed by Anteris Technologies Global Corp.

      10-K/A - Anteris Technologies Global Corp. (0002011514) (Filer)

      4/29/25 4:34:06 PM ET
      $AVR
      Industrial Specialties
      Health Care